应用
选项
-
CD3 Mouse mAb (PE-AF647)关联靶标: CD3E简短描述: mAb (UCHT1); Mouse anti Human CD3 Antibody (PE-AF647); Flow Cytometry种属反应性: 人(Human) 亚型: Mouse IgG1宿主种属: 小鼠(Mouse) 克隆号: UCHT1 偶联: PE-AF647
-
Mouse IgG (PE-AF647)简短描述: pAb; Isotype Control Antibody; Mouse IgG (PE-AF647); Flow Cytometry亚型: Mouse IgG宿主种属: 小鼠(Mouse) 偶联: PE-AF647
-
Goat Anti-Mouse IgG H&L (AF680)简短描述: pAb; Goat Anti-Mouse IgG H&L Antibody (AF680); IF/ICC, Flow Cytometry种属反应性: 小鼠(Mouse) 亚型: Goat IgG宿主种属: 山羊(Goat) 偶联: AF680
-
Goat Anti-Mouse IgG H&L (AF680) (Ready to use)简短描述: pAb; Goat Anti-Mouse IgG H&L Antibody (AF680); Flow Cytometry, IF/ICC种属反应性: 人(Human) 亚型: Goat IgG宿主种属: 山羊(Goat) 偶联: AF680
-
BST2/CD317 Rat mAb (AF647)关联靶标: BST2简短描述: mAb (927); Rat anti Mouse BST2/CD317 Antibody (AF647); Flow Cytometry种属反应性: 小鼠(Mouse) 亚型: Rat IgG2b宿主种属: 大鼠(Rat) 克隆号: 927 偶联: PE-AF647
-
Recombinant CD14 Antibody (PE-AF647)关联靶标: CD14简短描述: Recombinant (P02C06); Mouse anti Human CD14 Antibody (PE-AF647); Flow Cytometry种属反应性: 人(Human) 亚型: Mouse IgG2a宿主种属: 小鼠(Mouse) 克隆号: P02C06 偶联: PE-AF647
-
Goat Anti-Rabbit IgG H&L (AF680)简短描述: pAb; Goat Anti-Rabbit IgG H&L Antibody (AF680); IF/ICC, Flow Cytometry种属反应性: 兔(Rabbit) 亚型: Goat IgG宿主种属: 山羊(Goat) 偶联: AF680
-
Rat IgG (AF680)简短描述: pAb; Isotype Control Antibody; Rat IgG (AF680); Flow Cytometry亚型: Rat IgG宿主种属: 大鼠(Rat) 偶联: AF680
-
Annexin V-AF680种属: 人(Human) Accession #: P08758表达系统: E. coli 蛋白标签: No tag生物活性: Testing in progress
-
Rat IgG1-kappa (AF680)简短描述: Recombinant (HRPN); Rat IgG1-Kappa (AF680) Isotype Control Antibody; Flow Cytometry亚型: Rat IgG1宿主种属: 大鼠(Rat) 克隆号: HRPN 偶联: AF680
-
Syrian hamster lgG-kappa (AF680), anti-HEL简短描述: Recombinant; Isotype Control Antibody; Syrian hamster lgG-kappa (AF680), anti-HEL; Flow Cytometry种属反应性: 鸡(Chicken) 亚型: Syrian hamster lgG宿主种属: 叙利亚仓鼠(Syrian hamster) 偶联: AF680
-
Rat IgG2b-kappa (AF680), anti-Spike RBD简短描述: Recombinant; Isotype Control Antibody; Rat IgG2b-kappa (AF680), anti-Spike RBD; Flow Cytometry种属反应性: 严重急性呼吸系统综合征冠状病毒2型(SARS-CoV-2) 亚型: Rat IgG2b宿主种属: 大鼠(Rat) 偶联: AF680
首页
400-620-6333











